ONVO Prakiraan wutah bathi kanggo taun ngarep organovo.com

Lambang korporat lan logo Organovo (ONVO)

Can Organovo Holdings, Inc. (ONVO) maintain its leadership while losing ground to more dynamic competitors? The management's scientific potential has yet to translate into profit, although partnerships for 3D organ modeling for pharmaceutical testing are expanding. The projected EPS growth for the next fiscal year visualizes these expectations, and 0.00 captures the current value of the indicator.

Organovo Holdings Inc (ONVO): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 04.07.2022 nganti 24.04.2025

ONVO (Organovo Holdings): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:ONVO, organovo.com
Produk dadi Organovo

Organovo Holdings, Inc. (ONVO) developments in 3D bioprinting of liver tissues determine the potential for future innovation monetization, which is directly reflected in market expectations. This trend in consensus earnings per share estimates measures the dynamics of projected EPS revisions, allowing investors to compare analyst optimism with the company's actual ability to generate cash flow and service its obligations during a period of active research.

Analisis perusahaan pesaing

ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (Rhythm Pharma)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep akerotx.com AKRO|Metsera Therapeutics (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CRNX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi kanggo taun ngarep|SLNO - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Amicus Corp|89bio Pharma (ETNB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep agios.com (AGIO)|Prakiraan wutah bathi saben saham kanggo taun ngarep structuretx.com GPCR|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MiMedx Group Inc MDXG|Dinamika bathi saben saham sing diarepake ing taun ngarep RZLT|lexpharma.com - Prakiraan wutah bathi kanggo taun ngarep|MBX (MBX Biosciences Inc) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|ALT: Prakiraan wutah bathi kanggo taun ngarep|Aardvark Therapeutics Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|SGMT (Sagimet Biosciences, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep BioAge|Prakiraan wutah bathi kanggo taun ngarep BMEA|Prakiraan wutah bathi saben saham kanggo taun ngarep Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep VTVT|Agape ATP Corporation - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Pluri PLUR|SYBX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Lipocine Inc. (LPCN)|MTNB (Matinas BioPharma) - Prakiraan wutah bathi kanggo taun ngarep|sprucebiosciences.com (SPRB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Galecto Corp (GLTO)|CTCX - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Lumos Therapeutics LUMO|Radius Health (RDUS) - Prakiraan wutah bathi resik saben saham ing taun ngarep